
Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
15.830
Open
15.200
VWAP
15.68
Vol
264.44K
Mkt Cap
493.15M
Low
15.200
Amount
4.15M
EV/EBITDA(TTM)
6.39
Total Shares
32.15M
EV
651.71M
EV/OCF(TTM)
8.21
P/S(TTM)
0.65
The Marcus Corporation is engaged in the lodging and entertainment industries, with significant Company-owned real estate assets. The Company's segments include Theatres, and Hotels and Resorts. The Theatres segment owns or operates approximately 985 screens at 78 locations in 17 states under the Marcus Theatres, Movie Tavern by Marcus and Bistro Plex brands. The Company operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio, Arkansas, Colorado, Georgia, Kentucky, Louisiana, New York, Pennsylvania, Texas and Virginia and a family entertainment center in Wisconsin. The Hotels and Resorts segment owns and/or manages around 16 hotels, resorts and other properties in eight states. It owns and operates full-service hotels and resorts in Wisconsin, Illinois and Nebraska and manages full service hotels, resorts and other properties in Wisconsin, Illinois, Minnesota, Iowa, Nevada, Pennsylvania, California and Nebraska.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
155.80M
+4.73%
--
--
201.35M
+6.92%
--
--
215.09M
-7.56%
--
--
Estimates Revision
The market is revising Upward the revenue expectations for The Marcus Corporation (MCS) for FY2025, with the revenue forecasts being adjusted by 0.48% over the past three months. During the same period, the stock price has changed by -7.68%.
Revenue Estimates for FY2025
Revise Upward

+0.48%
In Past 3 Month
Stock Price
Go Down

-7.68%
In Past 3 Month
5 Analyst Rating
Wall Street analysts forecast MCS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MCS is 22.80 USD with a low forecast of 16.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 15.750

Low
16.00
Averages
22.80
High
25.00
Current: 15.750

Low
16.00
Averages
22.80
High
25.00
Wedbush
Outperform
initiated
$24
2025-07-18
Reason
Wedbush
Price Target
$24
2025-07-18
initiated
Outperform
Reason
Wedbush initiated coverage of Marcus with an Outperform rating and $24 price target. The firm sees the company benefiting from a more consistent theatrical release slate over the next several quarters. Marcus is positioned to to raise its dividend back toward pre-pandemic rates and repurchase shares, the analyst tells investors in a research note. Wedbush adds that Marcus has room to monetize surplus real estate as it owns most of its properties. It has a positive bias on the shares.
B. Riley
B. Riley
Buy
downgrade
$26 -> $24
2025-05-16
Reason
B. Riley
B. Riley
Price Target
$26 -> $24
2025-05-16
downgrade
Buy
Reason
B. Riley lowered the firm's price target on Marcus to $24 from $26 and keeps a Buy rating on the shares following a transfer of coverage. The firm is "generally constructive" on the exhibitor space, saying the sector is underpinned by a strong Hollywood film slate for 2025 and 2026 that should fuel further box office recovery and benefit relevant industry participants. Riley also finds limited tariff risk and a history of movie-going resiliency during periods of economic weakness "to be additional market themes that are supportive of this favorable backdrop." The firm's top pick across the group is Imax (IMAX), followed by Marcus (MCS).
Barrington Research
James Goss
Buy
Maintains
$27 → $25
2025-04-15
Reason
Barrington Research
James Goss
Price Target
$27 → $25
2025-04-15
Maintains
Buy
Reason
Barrington lowered the firm's price target on Marcus to $25 from $27 and keeps an Outperform rating on the shares. The firm expects a "soft" Q1 report still expects growth in 2025. It believes the company's Q1 theatre revenues will be close to the reported first quarter level in the year ago.
Benchmark
Mike Hickey
Strong Buy
Reiterates
$25
2025-04-11
Reason
Benchmark
Mike Hickey
Price Target
$25
2025-04-11
Reiterates
Strong Buy
Reason
Barrington Research
James Goss
Buy
Maintains
$27
2025-03-03
Reason
Barrington Research
James Goss
Price Target
$27
2025-03-03
Maintains
Buy
Reason
Barrington Research
James Goss
Buy
Maintains
$27
2025-02-27
Reason
Barrington Research
James Goss
Price Target
$27
2025-02-27
Maintains
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Marcus Corp (MCS.N) is 45.22, compared to its 5-year average forward P/E of 21.14. For a more detailed relative valuation and DCF analysis to assess Marcus Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
21.14
Current PE
45.22
Overvalued PE
87.10
Undervalued PE
-44.82
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
5.90
Current EV/EBITDA
7.56
Overvalued EV/EBITDA
54.34
Undervalued EV/EBITDA
-42.53
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
0.80
Current PS
0.60
Overvalued PS
1.03
Undervalued PS
0.57
Financials
Annual
Quarterly
FY2025Q2
YoY :
+18.37%
195.67M
Total Revenue
FY2025Q2
YoY :
+394.67%
13.19M
Operating Profit
FY2025Q2
YoY :
-136.20%
7.32M
Net Income after Tax
FY2025Q2
YoY :
-136.51%
0.23
EPS - Diluted
FY2025Q2
YoY :
-8.69%
14.73M
Free Cash Flow
FY2025Q2
YoY :
+4.22%
32.61
Gross Profit Margin - %
FY2025Q2
YoY :
-121.86%
-0.61
FCF Margin - %
FY2025Q2
YoY :
-130.58%
3.74
Net Margin - %
FY2025Q2
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
7.7K
USD
1
3-6
Months
42.8K
USD
1
6-9
Months
0.0
USD
0
0-12
Months
178.5K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
7.7K
USD
1
3-6
Months
42.8K
USD
1
6-9
Months
0.0
USD
0
0-12
Months
178.5K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
MCS News & Events
Events Timeline
2025-08-05 (ET)
2025-08-05
12:26:09
Marcus raises quarterly dividend to 8c from 7c per share

2025-08-01 (ET)
2025-08-01
07:48:51
Marcus reports Q2 adjusted EPS 17c, consensus 13c

2025-05-27 (ET)
2025-05-27
10:39:27
Marcus reports 'record' Memorial Day weekend at theatres

Sign Up For More Events
Sign Up For More Events
News
8.0
08-05NewsfilterMarcus Corporation Increases Quarterly Dividend
5.0
08-05NewsfilterPaul A. Leff Elected to Marcus Corporation Board of Directors
2.0
08-04BenzingaTop 3 Tech And Telecom Stocks That Could Blast Off In Q3
Sign Up For More News
People Also Watch

DXYZ
Destiny Tech100 Inc
28.450
USD
+4.02%

ODC
Oil-Dri Corporation of America
59.090
USD
+1.04%

EU
enCore Energy Corp
2.370
USD
+7.48%

LENZ
LENZ Therapeutics Inc
40.000
USD
+0.38%

PLPC
Preformed Line Products Co
193.390
USD
+4.78%

SMLR
Semler Scientific Inc
31.430
USD
+4.42%

IMNM
Immunome Inc
10.300
USD
+3.52%

MGIC
Magic Software Enterprises Ltd
20.390
USD
+2.72%

AUNA
Auna SA
6.180
USD
-1.59%

CAPR
Capricor Therapeutics Inc
7.100
USD
+1.21%
FAQ

What is Marcus Corp (MCS) stock price today?
The current price of MCS is 15.75 USD — it has increased 3.96 % in the last trading day.

What is Marcus Corp (MCS)'s business?

What is the price predicton of MCS Stock?

What is Marcus Corp (MCS)'s revenue for the last quarter?

What is Marcus Corp (MCS)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Marcus Corp (MCS)'s fundamentals?

How many employees does Marcus Corp (MCS). have?
